TMR-Logo.png
Pancreatic Cancer Treatment Market to Surge to USD 10.2 Billion by 2034, Driven by Advancements in Immunotherapies and Early Diagnostics – Transparency Market Research
February 06, 2025 11:00 ET | Transparency Market Research
Wilmington, Delaware, United States, Transparency Market Research Inc. - , Feb. 06, 2025 (GLOBE NEWSWIRE) -- The Pancreatic Cancer Treatment Market is set for remarkable growth, projected to reach...
CytoMed logo.png
CytoMed Therapeutics announces Chairman’s Letter to the Company’s shareholders
February 06, 2025 07:20 ET | CYTOMED THERAPEUTICS LIMITED
SINGAPORE, Feb. 06, 2025 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or the “Company”) today released a letter to shareholders from the Chairman of the Company’s Board...
medicenna.jpg
Medicenna Therapeutics to Participate in Two Healthcare Investor Conferences in February 2025
February 05, 2025 07:00 ET | Medicenna Therapeutics Corp.
TORONTO and HOUSTON, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage immunotherapy company focused...
TMR-Logo.png
Non-Muscle Invasive Bladder Cancer Market Poised for $21.1 Bn Surge by 2034, Driven by Expanding Therapeutic Innovations | Transparency Market Research
January 31, 2025 09:45 ET | Transparency Market Research
Wilmington, Delaware, Transparency Market Research Inc. –, Jan. 31, 2025 (GLOBE NEWSWIRE) -- The global non-muscle invasive bladder cancer (NMIBC) market (非筋肉浸潤性膀胱癌市場), valued at US$ 2.6 billion in...
CalidiBiotherapeutics-Logo@2x.jpg
Join Calidi Biotherapeutics’ Exclusive Live Investor Webinar and Q&A Session on February 5
January 29, 2025 08:00 ET | Calidi Biotherapeutics, Inc
SAN DIEGO, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor...
Cancer Immunotherapy Market
Cancer Immunotherapy Market, Valued at $125.68 Billion in 2025, Sees $194.64 Billion Opportunity by 2029 - Dominated by Amgen, AstraZeneca, Roche, Bayer, and Eli Lilly
January 28, 2025 11:29 ET | Research and Markets
Dublin, Jan. 28, 2025 (GLOBE NEWSWIRE) -- The "Cancer Immunotherapy Market Report 2025" has been added to ResearchAndMarkets.com's offering.This Cancer Immunotherapy market report covers market...
22157.jpg
CD137 Antibodies Market Research 2024-2027: Increasing Investment in the Cancer Therapeutics Domain, Involvement of Prominent Companies Driving the CD137 Market
January 28, 2025 11:13 ET | Research and Markets
Dublin, Jan. 28, 2025 (GLOBE NEWSWIRE) -- The "CD137 Antibodies Clinical Trials & Market Opportunity Insight" report has been added to ResearchAndMarkets.com's offering. The market potential...
CalidiBiotherapeutics-Logo@2x.jpg
Calidi Biotherapeutics Announces Bolstered Cash Balance and Termination of its Standby Equity Purchase Agreement
January 28, 2025 08:00 ET | Calidi Biotherapeutics, Inc
SAN DIEGO, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor...
Logo edited.jpg
Greenwich LifeSciences Announces Activation of Flamingo-01 in Poland
January 27, 2025 06:00 ET | Greenwich LifeSciences, Inc.
STAFFORD, Texas, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial,...
Straits Logo 1-01 (1).png
Biosimilars Market Size is Projected to Reach USD 121.88 Billion by 2033, Growing at a CAGR of 15.56%: Straits Research
January 23, 2025 09:30 ET | Straits Research Private Limited - Garner Insights
New York, United States, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Biosimilars, also known as follow-on biologics, are made by a different business but look and work much like the original medicine....